Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR1 | P21453 | 20/20 | 0.55 |
| ▸ | S1PR3 | Q99500 | 16/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1813721 | 0.89 | S1PR1 (0.57) | S1PR1S1PR3CYP3A4CYP2C8KCNH2 | |
| SCHEMBL21351558 | 0.84 | S1PR1 (0.53) | S1PR1S1PR3CYP3A4CYP2C8KCNH2 | |
| SCHEMBL1838597 | 0.84 | S1PR1 (0.53) | S1PR1S1PR3CYP3A4CYP2C8KCNH2 | |
| SCHEMBL21369273 | 0.82 | S1PR1 (0.62) | S1PR1S1PR3CYP3A4CYP2C8KCNH2 | |
| SCHEMBL1824129 | 0.82 | S1PR1 (0.62) | S1PR1S1PR3CYP3A4CYP2C8KCNH2 | |
| SCHEMBL1829401 | 0.79 | S1PR1 (0.72) | S1PR1S1PR3CYP3A4CYP2C8KCNH2 | |
| SCHEMBL1816649 | 0.79 | S1PR1 (0.72) | S1PR1S1PR3CYP3A4CYP2C8KCNH2 | |
| SCHEMBL1824134 | 0.75 | S1PR1 (0.56) | S1PR1S1PR3CYP3A4CYP2C8KCNH2 | |
| SCHEMBL12002377 | 0.74 | S1PR1 (0.58) | S1PR1S1PR3CYP3A4CYP2C8KCNH2 | |
| SCHEMBL1226926 | 0.73 | S1PR1 (0.62) | S1PR1S1PR3CYP2C8KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2592071-B1 | Tricyclic heterocyclic compounds | BRISTOL MYERS SQUIBB CO (US) | 2019-09-18 | — | — | EP | disclosed |
| EP-2592071-A1 | Tricyclic heterocyclic compounds | Bristol-Myers Squibb Company (US) | 2013-05-15 | — | — | EP | disclosed |
| EP-2493866-A1 | TRICYCLIC HETEROCYCLIC COMPOUNDS | Bristol-Myers Squibb Company (US) | 2012-09-05 | — | — | EP | disclosed |
| WO-2011059784-A1 | TRICYCLIC HETEROCYCLIC COMPOUNDS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2011-05-19 | — | — | WO | disclosed |